(2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid

Term ID

CHEBI:154671

Synonyms

2-deoxy-2-sulfoamino-alpha-D-gluco-hexopyranosyl-(1->4)-2-O-sulfo-L-ido-hexopyranuronic acid
GlcNS(a1-4)IdoA2S

Definition

References

glygen:G89699BW
glytoucan:G89699BW

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid

Phenotype where environments contain (2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid

Phenotype modified by environments containing (2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid

Phenotype affecting (2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid

Human Disease Model